Acute intake of a high-fructose diet alters the balance of adipokine concentrations and induces neutrophil influx in the liver

Journal of Nutritional Biochemistry

Volumn 25, Issue 4, 2014, Pages 388-394

  Rodrigues, Débora Fernandes ^a   Henriques, Milene Cristina do Carmo ^a   Oliveira, Marina Chaves ^a   Menezes Garcia, Zélia ^a   Marques, Pedro Elias ^a   Souza, Danielle da Glória ^a   Menezes, Gustavo Batista ^a   Teixeira, Mauro Martins ^a   Ferreira, Adaliene Versiani Matos ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Adipokines; Fructose; Neutrophils; Postprandial inflammation

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FRUCTOSE; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PENTRAXIN 3; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CHOLESTEROL; CYTOKINE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; LIVER; MALE; MOUSE; NEUTROPHIL; NONHUMAN; POSTPRANDIAL STATE; SUGAR INTAKE; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM;

MUS;

ADIPOKINES; ANIMALS; BIOLOGICAL MARKERS; CHOLESTEROL; CYTOKINES; FRUCTOSE; INFLAMMATION; LIVER; MALE; MICE, INBRED BALB C; NEUTROPHILS; POSTPRANDIAL PERIOD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84895925053     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.11.012     Document Type: Article

References (55)

1. Burton-Freeman B. Postprandial metabolic events and fruit-derived phenolics: a review of the science. Br J Nutr 2010, 104(Suppl 3):S1-S14.
2. Garber A.J. Postprandial dysmetabolism and the heart. Heart Fail Clin 2012, 8:563-573.
3. O'Keefe J.H., Bell D.S. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 2007, 100:899-904.
4. Aljada A., Mohanty P., Ghanim H., Abdo T., Tripathy D., Chaudhuri A., et al. Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr 2004, 79:682-690.
5. Margioris A.N. Fatty acids and postprandial inflammation. Curr Opin Clin Nutr Metab Care 2009, 12:129-137.
6. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Ann Rev Immunol 2011, 29:415-445.
7. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
8. Magne J., Mariotti F., Fischer R., Mathe V., Tome D., Huneau J.F. Early postprandial low-grade inflammation after high-fat meal in healthy rats: possible involvement of visceral adipose tissue. J Nutr Biochem 2010, 21:550-555.
9. Peluso I., Raguzzini A., Villano D.V., Cesqui E., Toti E., Catasta G., et al. High fat meal increase of IL-17 is prevented by ingestion of fruit juice drink in healthy overweight subjects. Curr Pharm Des 2012, 18:85-90.
10. Nappo F., Esposito K., Cioffi M., Giugliano G., Molinari A.M., Paolisso G., et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002, 39:1145-1150.
11. Malik V.S., Hu F.B. Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages. Curr Diab Rep 2012, 12:195-203.
12. Elliott S.S., Keim N.L., Stern J.S., Teff K., Havel P.J. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002, 76:911-922.
13. Stanhope K.L., Schwarz J.M., Keim N.L., Griffen S.C., Bremer A.A., Graham J.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009, 119:1322-1334.
14. Cox C.L., Stanhope K.L., Schwarz J.M., Graham J.L., Hatcher B., Griffen S.C., et al. Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. J Clin Endocrinol Metab 2011, 96:E2034-E2038.
15. Bagul P.K., Middela H., Matapally S., Padiya R., Bastia T., Madhusudana K., et al. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. Pharmacol Res 2012, 66:260-268.
16. Franz M.J., Bantle J.P., Beebe C.A., Brunzell J.D., Chiasson J.L., Garg A., et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002, 25:148-198.
17. Kelley G.L., Allan G., Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 2004, 145:548-555.
18. Kawasaki T., Igarashi K., Koeda T., Sugimoto K., Nakagawa K., Hayashi S., et al. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 2009, 139:2067-2071.
19. Stanhope K.L., Bremer A.A., Medici V., Nakajima K., Ito Y., Nakano T., et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab 2011, 96:E1596-E1605.
20. Barcelos L.S., Talvani A., Teixeira A.S., Cassali G.D., Andrade S.P., Teixeira M.M. Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice. Inflamm Res 2004, 53:576-584.
21. Marques P.E., Amaral S.S., Pires D.A., Nogueira L.L., Soriani F.M., Lima B.H., et al. Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure. Hepatology 2012, 56:1971-1982.
22. Lau D., Mollnau H., Eiserich J.P., Freeman B.A., Daiber A., Gehling U.M., et al. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A 2005, 102:431-436.
23. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
24. Netea M.G., Joosten L.A., Lewis E., Jensen D.R., Voshol P.J., Kullberg B.J., et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006, 12:650-656.
25. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002, 8:75-79.
26. Matthews V.B., Allen T.L., Risis S., Chan M.H., Henstridge D.C., Watson N., et al. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 2010, 53:2431-2441.
27. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H., Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000, 85:2970-2973.
28. Kallio P., Kolehmainen M., Laaksonen D.E., Pulkkinen L., Atalay M., Mykkanen H., et al. Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome. Am J Clin Nutr 2008, 87:1497-1503.
29. Dandona P., Aljada A., Mohanty P., Ghanim H., Hamouda W., Assian E., et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J Clin Endocrinol Metab 2001, 86:3257-3265.
30. Motton D.D., Keim N.L., Tenorio F.A., Horn W.F., Rutledge J.C. Postprandial monocyte activation in response to meals with high and low glycemic loads in overweight women. Am J Clin Nutr 2007, 85:60-65.
31. Gregersen S., Samocha-Bonet D., Heilbronn L.K., Campbell L.V. Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans. J Nutr Metab 2012, 2012:238056.
32. Smith S.R., Bai F., Charbonneau C., Janderova L., Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003, 52:1611-1618.
33. Rajala M.W., Qi Y., Patel H.R., Takahashi N., Banerjee R., Pajvani U.B., et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 2004, 53:1671-1679.
34. Lee B., Shao J. Adiponectin and energy homeostasis. Rev Endocr Metab Disord 2013, [Epub ahead of print].
35. Melanson K.J., Angelopoulos T.J., Nguyen V., Zukley L., Lowndes J., Rippe J.M. High-fructose corn syrup, energy intake, and appetite regulation. Am J Clin Nutr 2008, 88:1738S-1744S.
36. Kaser S., Kaser A., Sandhofer A., Ebenbichler C.F., Tilg H., Patsch J.R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003, 309:286-290.
37. Bruun J.M., Lihn A.S., Verdich C., Pedersen S.B., Toubro S., Astrup A., et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003, 285:E527-E533.
38. Moshyedi A.K., Josephs M.D., Abdalla E.K., Mackay S.L., Edwards C.K., Copeland E.M., et al. Increased leptin expression in mice with bacterial peritonitis is partially regulated by tumor necrosis factor alpha. Infect Immun 1998, 66:1800-1802.
39. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111:932-939.
40. Gruendel S., Weickert M.O., Garcia A.L., Wagner K., Pfeiffer A.F., Harsch I., et al. Serum resistin increases in a postprandial state during liquid meal challenge test in healthy human subjects. J Endocrinol Invest 2006, 29:RC27-RC30.
41. Yamauchi J., Osawa H., Takasuka T., Ochi M., Murakami A., Nishida W., et al. Serum resistin is reduced by glucose and meal loading in healthy human subjects. Metabolism 2008, 57:149-156.
42. Dallongeville J., Hecquet B., Lebel P., Edme J.L., Le Fur C., Fruchart J.C., et al. Short term response of circulating leptin to feeding and fasting in man: influence of circadian cycle. Int J Obes Relat Metab Disord 1998, 22:728-733.
43. Wiest R., Moleda L., Farkas S., Scherer M., Kopp A., Wonckhaus U., et al. Splanchnic concentrations and postprandial release of visceral adipokines. Metabolism 2010, 59:664-670.
44. Kubota N., Yano W., Kubota T., Yamauchi T., Itoh S., Kumagai H., et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007, 6:55-68.
45. Talukdar S., Oh da Y., Bandyopadhyay G., Li D., Xu J., McNelis J., et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 2012, 18:1407-1412.
46. Maher J.J., Scott M.K., Saito J.M., Burton M.C. Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 1997, 25:624-630.
47. Kanuri G., Spruss A., Wagnerberger S., Bischoff S.C., Bergheim I. Role of tumor necrosis factor alpha (TNFalpha) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem 2011, 22:527-534.
48. Ouedraogo R., Gong Y., Berzins B., Wu X., Mahadev K., Hough K., et al. Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 2007, 117:1718-1726.
49. Addabbo F., Nacci C., De Benedictis L., Leo V., Tarquinio M., Quon M.J., et al. Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-kappaB/COX-2 signaling in human aortic endothelial cells. Am J Physiol Endocrinol Metab 2011, 301:E1143-E1154.
50. Trellakis S., Rydleuskaya A., Fischer C., Canbay A., Tagay S., Scherag A., et al. Low adiponectin, high levels of apoptosis and increased peripheral blood neutrophil activity in healthy obese subjects. Obes Facts 2012, 5:305-318.
51. Hui J.M., Hodge A., Farrell G.C., Kench J.G., Kriketos A., George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatology 2004, 40:46-54.
52. Musso G., Gambino R., Biroli G., Carello M., Faga E., Pacini G., et al. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2005, 100:2438-2446.
53. Cancello R., Tordjman J., Poitou C., Guilhem G., Bouillot J.L., Hugol D., et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006, 55:1554-1561.
54. Hennige A.M., Staiger H., Wicke C., Machicao F., Fritsche A., Haring H.U., et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 2008, 3:e1765.
55. Kosteli A., Sugaru E., Haemmerle G., Martin J.F., Lei J., Zechner R., et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 2010, 120:3466-3479.